The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Expert review

Percutaneous septal ablation in hypertrophic obstructive ardiomyopathy: current status

EuroIntervention 2005;1:358-366 - DOI10.4244/EIJV1I3A59.

Department of Cardiology, Heart and Diabetes Centre North Rhine-Westphalia, University Hospital of the Ruhr University Bochum, D-32545 Bad Oeynhausen, Germany

Hypertrophic cardiomyopathy (HCM) is a cardiac condition morphologically characterized by unexplained myocardial hypertrophy. The prevalence of the disease is considered to be 0,1-0,5%, obstruction to left ventri

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Detection of a necrotic core-rich, highly deformable plaque in an angiographically non-diseased proximal LAD